Tough Slogging Ahead for Investors, Diversification is Important
March 07, 2022 at 14:13 PM EST
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.
